| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.072 | 0.04 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |